*Data updated daily at 18:00 EAT
Blink Pharma, one of the leading platforms for managing transactions between healthcare professionals, has successfully completed its first round with the Azur Innovation Fund Investment Fund to fund the development of its operations, including the launch of new products for the healthcare sector.
The B2B marketplace allows pharmacists, laboratories, and wholesalers to exchange orders and provide them with a payment method. The platform enables the transmission of orders from pharmacists to laboratories and wholesalers and also carries out the commercial transaction thanks to a system that complies with Law 17-04. The platform also offers a news and information section and already has a network of more than 3,500 pharmacists subscribing to the service.